Filing Details
- Accession Number:
- 0001209191-19-047612
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-28 16:36:52
- Reporting Period:
- 2019-08-26
- Accepted Time:
- 2019-08-28 16:36:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1606645 | Foamix Pharmaceuticals Ltd. | FOMX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1369219 | Anna Kazanchyan | C/O Foamix Pharmaceuticals Ltd. 2 Holtzman Street Rehovot L3 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2019-08-26 | 7,049 | $3.27 | 37,498 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
